使用DEVI和CARPREG-I评分预测患有膜心脏病的孕妇的心脏不良事件:来自MPAC注册表的外部验证研究

Gnanaraj Justin Paul1, Steaphen Anne Princy2, Surendran Anju1

  • 1Institute of Cardiology, Rajiv Gandhi Government General Hospital, Madras Medical College, Parktown, Chennai, Tamil Nadu, India.

Journal of cardiology
|March 26, 2025
PubMed
概括

两种风险工具,DEVI和CARPREG-I,有效预测怀孕妇女心脏膜疾病 (VHD) 的心脏事件. 虽然有用,但两者都需要重新校准,以提高临床环境中的准确性.